Pfizer may also consider retaining the business, one of the largest over the counter products businesses in the world, operating in 90 countries. It markets two of the ten top-selling consumer ...

The drugmaker’s fastest-growing blockbuster could soon face competition from two biotech firms in the treatment of a ...

over-the-counter treatments and diagnostic tests for diseases like migraine, Covid-19 or flu, and adult vaccinations. Pfizer, which is going through a cost-cutting program after misreading future ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The company joins Eli Lilly in offering its own digital platform to more directly connect to patients, allowing them easier access to healthcare providers and prescription drugs.

To start, according to Pfizer’s launch announcement Tuesday ... via the digitally powered Alto Pharmacy and purchase over-the-counter tests and treatments for COVID, flu and more via grocery ...

A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts ... There's no world yet on whether a counter-suit may be in ...

AUSTIN (KXAN) — COVID-19 cases are on the rise once again, with the number of emergency room visits increasing since May, according to the Center for Disease Control and Prevention. To counter ...

Pfizer reported second-quarter 2024 adjusted earnings per share of 60 cents, which comfortably beat the Zacks Consensus Estimate of 45 cents per share. Earnings declined 11% year over year.

Struggling with plunging demand for its Covid products, Pfizer Inc. has a ... Sizable bets on cancer therapies have yet to win over Wall Street. Pfizer Chief Executive Officer Albert Bourla ...